While We’re at It, Let’s Whack the FDA

The author takes issue with aspects of the Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) bill and recounts the U.S. Food and Drug Administration’s recent record on cancer drug approvals.

Detalles Bibliográficos
Autor principal: Chabner, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786363/
https://www.ncbi.nlm.nih.gov/pubmed/26869585
http://dx.doi.org/10.1634/theoncologist.2016-0041
Descripción
Sumario:The author takes issue with aspects of the Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) bill and recounts the U.S. Food and Drug Administration’s recent record on cancer drug approvals.

Ejemplares similares